HIAA

Related by string. * * AAHP HIAA *

Related by context. All words. (Click for frequent words.) 51 pmol L 49 mol L 49 P ≤ 48 mesangial 48 % CI #.#-#.# [001] 48 phosphorylated tau 48 posttreatment 48 mg p = 48 μmol L 48 mU liter 47 nmol 47 urinary excretion 47 % CI #.#-#.# [008] 47 bronchioloalveolar carcinoma 47 NNT = 47 serum GGT 47 Xalatan R 47 glucocorticoid induced 46 mg BID dose 46 lymphocytosis 46 TIMP 1 46 IFN alfa 46 ‰ ¥ 46 #.#/#.# mmHg [001] 46 μg mL 46 ALT elevation 46 TIMP 46 oxycodone CR 46 P = .# 46 serum concentrations 46 serologically active patients 46 intraabdominal 46 univariate analyzes 46 Secondary efficacy endpoints 46 nondiabetic patients 46 % CI #.#-#.# [003] 45 mmHg p = 45 Supplementary Table 45 BALF 45 Supplemental Figure 45 seropositivity 45 IQR 45 lymphocyte count 45 r2 = 45 BPS IC 45 PaO 2 45 undergoing radical cystectomy 44 echocardiographic parameters 44 HBeAg negative patients 44 CR CRu 44 QTcF 44 univariate analysis 44 idraparinux 44 NMIBC 44 oral diclofenac 44 vasopressor 44 Abstract P# [002] 44 CI #.#-#.# p = 44 euthyroid 44 urine albumin 44 p = .# [002] 44 subscale scores 44 COMT genotype 44 DAS# CRP 44 sodium nitroprusside 44 HbA 1c levels 44 Talsyn 44 baseline FEV 44 multivariable adjusted 44 mucosal inflammation 44 postintervention 44 mL/min/#.# m 2 44 % CI #.#-#.# [007] 44 gm dl 44 % Confidence Interval 43 Angiotensin converting enzyme 43 LDL triglycerides 43 clinicopathological 43 Main Outcome Measure 43 Cystatin C 43 Kaplan Meier estimates 43 #.#-#.# p = 43 interquartile range 43 Skin sterol 43 stimulated insulin secretion 43 PCWP 43 CI -#.# 43 Multivariate analysis 43 statistical significance p 43 confidence interval #.#-#.# 43 mmHg diastolic 43 arterial thromboembolic events 43 symptomatic intracranial hemorrhage 43 thyroid carcinoma 43 fludarabine cyclophosphamide 43 AUCs 43 mean baseline A1C 43 UPDRS scores 43 albumin excretion rate 42 ANCOVA 42 recurrent venous thromboembolism 42 biochemical relapse 42 pg ml 42 Prostate specific antigen 42 p ≤ 42 TT genotype 42 colorectal adenoma 42 artery occlusion 42 ß = 42 retrospective cohort 42 IPAH 42 p = NS 42 thrombocytopenic 42 LV ejection fraction 42 serum alkaline phosphatase 42 creatinine ratio 42 receiving VICTRELIS 42 tHcy 42 rs# [004] 42 aOR 42 mIU L 42 plasma adiponectin 42 subscales 42 Operative mortality 42 CR nPR 42 Pearson correlation coefficient 42 undetectable HBV DNA 42 BMS p = 42 TURBT 42 intima media thickness 42 Hb A1C 42 NACDD 42 Index FSFI 42 Cardiogenic shock 42 FluCAM arm 42 autologous SCT 42 â ‰ ¥ 42 multivariable analysis 42 nonsignificant difference 42 bioavailable testosterone 42 SUVmax 42 IIEF 41 MBq 41 Secondary endpoints include 41 sensory neuropathy 41 HOMA IR 41 NYHA functional class 41 ertapenem 41 #OHD 41 nadroparin 41 MADRS score 41 Partial Response 41 preoperative PSA 41 malignant neoplasm 41 -#.# ± [002] 41 highest tertile 41 Main Outcome Measures 41 PSADT 41 LGG 41 noncardiovascular mortality 41 Organ Procurement Organizations 41 xenograft model 41 pT3 41 histologically proven 41 salmeterol fluticasone propionate 41 HBeAg seroconversion 41 intraperitoneally 41 ProVen 41 HBeAg 41 % CI #.#-#.# [004] 41 GG genotype 41 pT2 41 x ULN 41 hormone receptor negative 41 μg ml 41 achieved ACR# 41 % CI #.#-#.# [006] 41 Platelet counts 41 pretransplant 41 tPSA 41 atazanavir ritonavir 41 Secondary endpoints included 41 specific alkaline phosphatase 41 CI #.#-#.# [001] 41 Fig. 3b 41 atorvastatin #mg 41 mean baseline HbA1c 41 IOP lowering 41 response pCR 41 mIU ml 41 PSA nadir 41 statistically significant p = 41 pCR 41 detrusor overactivity 41 coronary stenosis 40 #p# [003] 40 clinically meaningful improvement 40 estimated GFR 40 complete cytogenetic response 40 microg 40 p = #.# [003] 40 pulmonary exacerbations 40 postop 40 pg mL 40 prespecified secondary 40 carboxy 40 confidence interval CI 40 lymphovascular invasion 40 multivariate adjustment 40 enterococcal 40 multivariate analyzes 40 T1c 40 CI #.#-#.# [002] 40 UPDRS motor 40 p = .# [001] 40 HRQoL 40 mmol L. 40 neuropathy sensory 40 oblimersen 40 confidence intervals CIs 40 cytologic 40 recurrent DVT 40 collagenous colitis 40 anastomotic leaks 40 Viread Emtriva SUSTIVA 40 iodixanol 40 NADP 40 microbiologically evaluable 40 ximelagatran 40 % CI #.#-#.# [005] 40 adriamycin 40 noncardiac 40 mU L 40 cm H2O 40 invasive lobular 40 advanced hepatocellular carcinoma 40 MGUS 40 carotid artery thickness 40 #p#.# [001] 40 familial aggregation 40 PDSS 40 lumbar spine BMD 40 tertiles 40 binary restenosis 40 Papillary 40 = .# 40 β = 40 aged ≥ 40 rho = 40 metabolomic profiles 40 Hazard Ratio 40 mL kg 40 subscore 40 regression coefficient 39 5-FU/LV 39 OVX 39 HGPIN 39 Injury Severity Score 39 CALGB # [002] 39 atherothrombotic 39 drotrecogin alfa activated 39 debulking surgery 39 seminal vesicle invasion 39 Hazard Ratio = 39 SGRQ 39 Chronic Obstructive Lung 39 Score DAS# 39 Kaplan Meier 39 parous women 39 atrial natriuretic peptide 39 lowest tertile 39 leukemia lymphomas 39 AAO HNS 39 ATV RTV 39 del 5q 39 IIQ 39 CRp 39 Bob Barocci 39 nonobstructive 39 ratio ICER 39 surgically resected 39 prednisone prednisolone plus 39 CC genotype 39 amoxicillin clavulanate 39 androgen suppression 39 AHR 39 CTEPH 39 n = 39 sociodemographic factors 39 heterozygotes 39 pretreatment serum 39 nonvertebral fracture 39 treat NNT 39 preintervention 39 underwent resection 39 advanced adenoma 39 neurologic impairment 39 nonfatal MI 39 hemoglobin hematocrit 39 5q 39 FOLFIRI alone 39 multiple logistic regression 39 portal vein thrombosis 39 mL/min/#.# m2 39 cyclophosphamide methotrexate 39 HSCR 39 FDG PET scan 39 spud #-#-# drlg [004] 39 variant rs# 39 NNRTI resistance 39 antiretroviral naïve 39 Adjuvant chemotherapy 39 Dexx & 39 CIN2 + 39 odds ratios ORs 39 inhospital mortality 39 CRQ 39 ECLS 39 multivariable Cox 38 HLA A2 38 node metastases 38 bivariate 38 SSc 38 Ischemic heart 38 NIH CPSI 38 borderline statistical significance 38 SDQ 38 KDOQI 38 Gynecological Cancer 38 comorbid 38 Cardiopulmonary bypass 38 -#.# p = 38 squamous intraepithelial lesions 38 Median PFS 38 Oncotype 38 CsA 38 HIV uninfected 38 International Prognostic Scoring 38 HCV antibody 38 ventilation perfusion 38 elevated transaminases 38 Health Research SWHR 38 point Likert scale 38 serum biomarker 38 chromosome #q#.# [002] 38 BSIs 38 nonexposed 38 p = ns 38 IMA Absolute Return 38 statistical significance p = 38 function subscale 38 histologically confirmed 38 PABC 38 ERBB2 38 RBC transfusion 38 AAHAM 38 hc2 38 ezetimibe simvastatin 38 38 clodronate 38 hypertension hypercholesterolemia 38 logistic regression model 38 tipranavir ritonavir 38 carotid IMT 38 -#.# ± [001] 38 diameter stenosis 38 HRQL 38 adjuvant radiotherapy 38 plus medroxyprogesterone acetate 38 Endocrine Society #st 38 metronidazole gel 38 AADE 38 df = 38 seronegative 38 -#.# log# 38 Southeast Anesthesiology Consultants 38 Logistic regression 38 symptomatic intracerebral hemorrhage 38 ENGAGE AF TIMI 38 polyp recurrence 38 median PFS 38 statistically significant p 37 ug dose 37 dose atorvastatin 37 invasive carcinomas 37 cytoreductive nephrectomy 37 PSQI 37 Cl TSX 37 Puls Biznesu pp. 37 normotensive 37 EORTC QLQ C# 37 primary ciliary dyskinesia 37 AAHP 37 CI = 37 parasitological 37 FGFR4 37 catheter colonization 37 progression TTP 37 NAPHS 37 BEXXAR Therapeutic Regimen 37 RECIST criteria 37 MetS 37 atherosclerotic renal artery stenosis 37 ^ sup + 37 interval #.#-#.# 37 Symptom Checklist 37 ECOG PS 37 prostate cancer CaP 37 ARCOXIA 37 hyperhomocysteinemia 37 CNH Equipment 37 VFQ 37 Oncotype DX Recurrence Score 37 BPRS 37 cytogenetic abnormalities 37 CYPHER ® 37 latent celiac disease 37 renal allograft 37 conjugated equine estrogens 37 Multivariate analysis revealed 37 Comorbidity 37 MMSE score 37 Kaplan Meier analysis 37 spud #-#-# drlg [002] 37 HRCT 37 RECIST 37 = #.#-#.# 37 AAKP 37 Fin Serv 37 placebo p = 37 atrophic gastritis 37 eplerenone 37 nonsignificant 37 Cognitively Impaired 37 multivariable logistic regression 37 p = #.# [002] 37 logistic regression analysis 37 fluoropyrimidine 37 subscores 37 oncological outcomes 37 covariate 37 Canara Robeco Balance 37 EuroSCORE 37 familial AF 37 nodal metastasis 37 HF hospitalization 37 IPSS 37 catechol O methyltransferase 37 tamoxifen Nolvadex ® 37 RNA copies mL 36 CAPITAL ACCOUNT 36 plasmacytoid 36 Brief Psychiatric 36 pain subscale 36 p = #.# [004] 36 CIBIC plus 36 placebo p 36 conditional logistic regression 36 AOR = 36 r = 36 inflammatory rheumatic 36 TRIST 36 mITT population 36 sd = 36 SMRP 36 JOE 'S RESTAURANT 36 ISPOR 36 NACHC 36 anagrelide 36 Chris Rivas Buell 36 lacunar 36 Molecular Pathology AMP 36 subclinical atherosclerosis 36 subjective sleepiness 36 Kaplan Meier method 36 gene APOE 36 distant metastasis 36 esophagus bladder 36 advanced adenomas 36 Global Impression CGI 36 Compl. ¶ ¶ 36 β blockers 36 HGD 36 recurrent VTE 36 lymph node metastasis 36 adverse cytogenetics 36 ß blockers 36 pretest probability 36 extracapsular extension 36 NYSE CSFS 36 Cronbach alpha 36 thromboemboli 36 laparoscopic radical nephrectomy 36 periprocedural 36 Pac Lf 36 sleeve lobectomy 36 Ansvar 36 LV systolic function 36 multivariate Cox 36 NMFTA 36 OPRM1 36 mutated p# 36 radiotherapy RT 36 Efficiency ratio taxable 36 Gazeta Wyborcza pp. 36 CSMLS 36 β thalassemia 36 Severity CGI S 36 thromboembolism 36 Gawain Briars 36 Cl b Nv 36 EOX 36 p = 36 pegylated interferon alfa 2b 36 mean ± SEM 36 mHRPC 36 hydronephrosis 35 lowest quintile 35 Kruskal Wallis test 35 Parallax Fund 35 mesilate 35 Amer Cent 35 NSSEA 35 preoperative chemotherapy 35 CRu 35 NEFAR 35 CI 35 T1a 35 LV dysfunction 35 ischemia driven 35 recessively inherited 35 DBMD 35 -#.# mmol L 35 NAASO 35 CGIC 35 antibiotics metronidazole 35 Collectors Universe NASDAQ CLCT 35 statistically significant predictor 35 prostatic adenocarcinoma 35 Evaluable 35 Suicide Prevention IASP 35 apoE4 carriers 35 radical prostatectomy RP 35 Diabetes Educators AADE 35 nonischemic 35 % CI #.#-#.# [002] 35 SNP rs# [002] 35 malignant phenotype 35 WOMAC pain 35 biochemical recurrence 35 -#.# mm Hg 35 Renal Physicians 35 PFCD 35 Lori McIlwain 35 DM2 35 CI -#.# -#.# 35 mg clopidogrel 35 AIUM 35 simvastatin #mg 35 spontaneous bacterial peritonitis 35 peri procedural 35 RIGScan R 35 APHL 35 mmol L 35 ALTE 35 SCDAA 35 Assisted Living NCAL 35 ATRI 35 Charlson comorbidity index 35 Tourette Syndrome Association 35 TPV r 35 symptomatic DVT 35 IIIb 35 Breast Surgeons 34 cilostazol 34 β blocker 34 NAPHIA 34 NAA 34 prevalences 34 Alzheimer Disease Facts 34 SCZ 34 Cruz Pedregon Monte Carlo 34 liver transplant recipients 34 Plasma Protein Therapeutics 34 Lung Cancer Partnership 34 Pr TSX 34 LVEF 34 NAPH 34 FLOMAX 34 Quality Forum NQF 34 Wendy Fournier 34 IRLS 34 nonfatal stroke 34 WR Berkley NYSE WRB 34 VT VF 34 Patrick Pierra 34 GCAN 34 Postmenopausal hormone therapy 34 Parkin DM 34 PSGs 34 EQ 5D 34 ipsilateral stroke 34 Stent p = 34 Chronic Disease Directors NACDD 34 Hg 34 gastroduodenal 34 secondary efficacy endpoint 34 Thyroid Cancer Survivors 34 advanced pancreatic neuroendocrine 34 obstructive CAD 34 anthracycline containing 34 interrater reliability 34 IFIS 34 DAS# [002] 34 beta coefficient 34 correlation coefficients 34 MSCI NYSE MXB 34 QRS duration 34 ACNP 34 thrombotic microangiopathy 34 de novo coronary artery 34 Recap BAL 34 completely resected 34 Pr Ser TSX 34 Pneumocystis carinii pneumonia 34 visit www.conservation.org 34 Neurobiological 34 CFQ R 34 adefovir treated 33 MYB 33 NYSAR 33 Transplantation AST 33 acute cholecystitis 33 Preoperatively 33 placebo Hazard Ratio 33 -#.# USD JPY [002] 33 Affiliated Insurers 33 Nrg 33 HFSA 33 Intelligence Network NCIN 33 achieve sustained virological 33 biopsy Gleason 33 PCSM 33 IXJ 33 mRS 33 ASNR 33 Skylon Capital 33 NFV 33 Awwa Research 33 advanced neoplasia 33 Private Label Manufacturers 33 Angelyn Hernandez 33 Rita Shreffler 33 SF #v# 33 AcademyHealth 33 kappa = 33 QVAR R 33 SCA SCA 33 Median progression 33 Niemann Pick type 33 #.#-#.# [005] 33 WHH 33 sq cm 33 Consolidated Edison Inc 33 CI# [002] 33 ECG abnormalities 33 sero positive 33 Linear regression 33 SBP DBP 33 NAPNAP 33 NRTI sparing 33 Linda Groah RN MSN 33 Etf Un TSX 33 ± 33 IPTp 33 Elizabeth Nabel 33 BJALCF 33 CORE OM 33 AMWA 33 Normalized EPS 33 Relapsing remitting 33 undergo percutaneous coronary 33 hematologic toxicity 33 NACD 33 Rating Scale BPRS 33 TNSMI 32 myocardial infarction stroke 32 ASHG 32 LIF 32 Biodel NASDAQ BIOD 32 HLA DRB1 SE 32 OASI 32 total cholesterol HDL 32 MidAtlantic Employers Association 32 pulsatility index 32 HPFS 32 interrater 32 Vascular Stent 32 Pricesmart NASDAQ PSMT 32 Axa SA -#.# 32 angiographically 32 ACI NA 32 National Alopecia Areata 32 haematological toxicity 32 NACHRI 32 n4a 32 Jeevan Akshay 32 bivalirudin alone 32 ABIH 32 reinfarction 32 CPX 32 Brompton Advantaged Tracker 32 carotid artery ICA 32 Megan Ronk 32 AAPM 32 SPECIFICS Hosston 32 Chemical Distributors NACD 32 SCIP 32 CUSIP #G# 32 ABPA 32 SMEI 32 CIBIC + 32 PEY 32 Markham Stouffville 32 intraclass correlation coefficients 32 Poison Control Centers AAPCC 32 PKY 32 MarketingExperiments.com 32 highest quintile 32 lymphadenectomy 32 Toxics Release Inventory TRI 32 CIAB 32 NAAG 32 TAVMA 32 SELENA SLEDAI 32 Medisys 32 Rockwater Capital 32 bivalirudin monotherapy 32 SAMHSA 32 National Nutritional Foods 32 antithrombotic therapy 32 Continence NAFC 32 HZW 32 AAPPO 32 Class Pr TSX 32 EGFR mutation positive 31 Seattle Angina Questionnaire 31 nonfatal myocardial infarction 31 AHQA 31 Abnormal Involuntary Movement 31 Corp. Pr TSX 31 Clean Water Agencies NACWA 31 multivariate adjusted 31 Sirona Holdings Luxco 31 pN 31 TRUS 31 Faircourt Asset Management 31 CFBAI 31 PIA XI top 31 CABG p = 31 QALYs 31 PYN 31 diastolic velocity 31 independent prognostic marker 31 ASCO Breast Cancer 31 Companhia Siderugica Hacional 31 Megace ® 31 intraclass correlation coefficient 31 Neenah Paper NYSE 31 Transportation Intermediaries 31 Stage IIIb 31 HFN database 31 DAA 31 NAPCOR 31 #a #a [003] 31 Confidence Intervals 31 correlation coefficient 31 PCa 31 Adjusted Margin 31 Psychiatric Publishing 31 FCER 31 Reusable Packaging Association 31 Mailers Technical 31 YLO.UN 31 Platelet Disorder Support 31 RNFL thickness 31 NYLIM 31 Interest Coverage Ratio 31 Angelman Syndrome Foundation 31 CWLA 31 CHD 31 MTIA 31 DAST 31 sustained ventricular tachycardia 31 Investable Index 31 PPPC 31 Yield Bond 31 HBV infected 31 Dorval Artists 31 31 observational cohort 31 Negro Women NCNW 31 Mackenzie Cundill Value 31 Newsflashes 31 BlackRock MuniVest Fund 31 PLND 31 AGIC 30 Baroness Peta Buscombe 30 MC# [001] 30 Mary Trupo 30 CurrencyShares Swedish Krona 30 CASRO 30 colorectal neoplasms 30 THOMPSON CREEK METALS 30 CIBIC Plus 30 USFCC 30 ACDIS 30 BoardSource 30 Zena Ramatali 30 multivariate analysis 30 Rydex Inverse 2x 30 CBV 30 EMBLEM TM 30 EHP 30 Autism Consortium 30 ACGIH 30 Preventive Cardiovascular Nurses 30 TGZ 30 NHCA 30 PIANJ 30 Australian Lot Feeders 30 ICAM 30 pT 30 Acuity Funds 30 BTZ 30 IFN beta 1a 30 NSGIC 30 RICE BRAN Rs 30 Newspaper Audience Databank 30 AABB 30 ALA 30 BHTA 30 National Advertisers ANA 30 PKD Foundation 30 Net Tangible Assets 30 ppm deg 30 STRATA 30 Jesse Slome 30 SecureInfo RMS 30 NADbank 30 Maryland Aviation Administration 30 NAMS 30 diversiTrust TM Energy 30 PHILADELPHIA Hersha Hospitality 30 Research Diagnostic Criteria 30 ROC curve 30 FLT 30 NATSO 30 Milwaukee NARI 30 CML Healthcare 30 MarketingProfs.com 30 NARTS 30 Marcilio Alves treasurer 29 IIABA 29 CF Miton 29 KRAS gene mutations 29 PSDA 29 NPMA 29 ACNM 29 IASLC 29 Kaitz Foundation 29 Document Maker 29 untreated CLL 29 noninferiority 29 Mid Cap Core 29 TNM 29 Universal UVV 29 NorCal BMA 29 Friends Provident LSE 29 Morgan Stanley Emerging Markets 29 Unitrin +#.# 29 Suicidology 29 leading midtail web 29 Health Underwriters NAHU 29 DSRTF 29 Medical Colleges AAMC 29 AAASC 29 Bovi Shield GOLD 29 RSES 29 AFSMI 29 Evton Real Estate 29 Live Equiv 29 Circumpolar Biodiversity Monitoring 29 HEDNA 29 Transglobe Energy 29 Tredegar Corporation 29 BNX 29 Related Institutions 29 Frontotemporal Dementias 29 GARS 29 IPMA HR 29 proportional hazards 29 CMR 29 BRAC RTF 29 Addiction Professionals 29 coincident composite index 29 Hemophilia Foundation 29 clinically evaluable CE 29 AUTOMATIC WITH OVERDRIVE 29 Addiction Treatment Providers 29 Assessment Scale 29 CELESTICA 29 OZG 29 CAMY 29 NAICU 29 ASIPP 29 Management IREM 29 Greg Principato 29 undergoing coronary angiography 29 MMF 29 CEA 29 NAESP 29 Independent Petroleum Marketers 29 Panoro Minerals 29 CI Mutual Funds 29 NATT 29 Disease Activity 29 BULLETIN TYPE Graduation 29 ICD 29 RAAA 29 1st Pr TSX 29 FER 29 BNAR 28 NP 28 ¶ ¶ #-# 28 Claymore Tax Advantaged 28 Forrester Customer Experience 28 Assante Wealth Management 28 KeySpan Facilities 28 Geologic Resource 28 Sanjay Sabnani CrowdGather 28 Marketocracy Capital 28 Cigna Corp 28 fatal myocardial infarction 28 HBAA 28 Neurological Surgeons AANS 28 Chemical Coaters Association 28 NHPCO 28 CAAMP 28 NLGA 28 School Nurses NASN 28 BCFM 28 Water Companies NAWC 28 FPH 28 Assante Asset Management 28 AIHA 28 Wechsler Adult 28 Francois Barthelemy 28 Children Craniofacial 28 IASC Foundation 28 PRIMIR 28 standard deviation 28 Dillards DDS 28 CoreLogic CLGX 28 WQA 28 AAPA 28 Association Executives ASAE 28 CAMB 28 BioInformatics 28 AACE 28 DMAI 28 DTC Perspectives 28 Remote Sensing ASPRS 28 Barbara Harsha 28 NEPT 28 VBMA 28 FAAN 28 Barbara Tulipane 28 systemic embolism 28 QIOs 28 Aweida Capital 28 P. GUTIERREZ 28 endovascular graft 28 JACC 28 AllBlue 28 AAMGA 28 VNB 28 CIBC CM 28 ADCOLOR R 28 American Railroads AAR 28 Jayant Davar 28 Tissue Banks AATB 28 Jed Hilly 28 ACCF 27 NACAA 27 exemestane 27 CCTE 27 LONG BEACH Mffais.com Voyageur 27 AIChE

Back to home page